Risk Factor Control Five Years after Coronary Bypass Grafting

The prevalence of three major coronary risk factors, hyperlipidaemia, hypertension and cigarette smoking, and the change in lipid fractions were assessed five years after coronary bypass surgery and compared to pre-operation in 353 consecutive patients undergoing elective first time surgery at a single centre. Five years after surgery 309 patients were alive without further cardiac surgery, questionnaire follow-up was available in 291 (94%). Lipid profile measurements were made in 255 (83%) of these five-year survivors and 100 (34%) had a history of hypertension. Five years after surgery, 146 (50%) of the 291 patients thought they had high cholesterol, of whom 92 (63%) were following a diet, 36 (25%) were also taking lipid-lowering drugs and 18 (12%) were taking no measures; 141 (48%) of them did not think they had high cholesterol, and four (2%) did not know. There had been a favourable change in all lipid fractions compared with pre-operation, including total serum cholesterol, particularly in patients taking lipid-lowering drugs. However, total serum cholesterol was above 5.2 mmol/l in 203 (80%) patients and low-density lipoprotein (LDL) cholesterol was above 3.4 mmol/l in 180 (71%). Only 30% of patients taking lipid-lowering drugs had an LDL cholesterol of 3.4 mmol/l or less. Blood pressure was recorded in 257 (83%) of the 309 five-year survivors: 82 (28%) were taking antihypertensive medication; 32 (12%) and 87 (34%) patients had a diastolic blood pressure above 95 mmHg and 90 mmHg, respectively, and 49 (19%) had a systolic blood pressure above 160 mmHg. There were 22 (9%) regular cigarette smokers. Corroboration of non-smoking with exhaled carbon monoxide measurements confirmed an accurate history of non-smoking in nearly all patients.

[1]  H. Daida,et al.  Relation of saphenous vein graft obstruction to serum cholesterol levels. , 1995, Journal of the American College of Cardiology.

[2]  Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.

[3]  M. Buchalter,et al.  Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit. , 1994, British heart journal.

[4]  J. Simons,et al.  Coronary risk factors 6‐12 months after coronary artery bypass grafting: Comparison of surveys in 1986, 1990 and 1994 , 1994, The Medical journal of Australia.

[5]  G. Bondjers,et al.  Serum triglycerides and HDL cholesterol--major predictors of long-term survival after coronary surgery. , 1994, European heart journal.

[6]  D. Betteridge,et al.  Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. , 1993, Postgraduate medical journal.

[7]  C. Bulpitt,et al.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. , 1993, BMJ.

[8]  R H Jones,et al.  Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. , 1991, Circulation.

[9]  S. Azen,et al.  Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. , 1990, JAMA.

[10]  W. Roberts Recent studies on the effects of beta blockers on blood lipid levels. , 1989, American heart journal.

[11]  D H Blankenhorn,et al.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.

[12]  S. Wacholder,et al.  The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. , 1984, The New England journal of medicine.

[13]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[14]  B. Gersh,et al.  Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. , 1992, Journal of the American College of Cardiology.

[15]  G. Lawrie,et al.  Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years. , 1991, Annals of surgery.

[16]  R. Hoffmann,et al.  Risk factors among patients undergoing repeat aorta-coronary bypass procedures. , 1987, The Journal of thoracic and cardiovascular surgery.